Relapsed/Refractory Multiple Myeloma Drug by Takeda Receives Negative Opinion from EMA
Takeda Pharmaceutical Company Limited has recently received a negative…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Multiple Myeloma Among Topics in APSHO Educational Series for Healthcare Workers
The Advanced Practitioners Society for Hematology and Oncology…
New Data from Key Trial of Kyprolis to Treat Advanced Multiple Myeloma Shows Benefits
Amgen reported findings from a post-hoc analysis of the pivotal Phase…
Positive Results from Phase 3 Trial of Combo Therapy for Multiple Myeloma Presented at ASCO 2016
Researchers from Janssen Research & Development presented promising interim…
Study Reveals Multiple Myeloma Treatment Disparities Between Caucasian, African-American Patients
Celgene Corporation recently presented a study comparing overall survival, treatment…
Founder of Multiple Myeloma Research Foundation Named Co-Chair of Harvard’s Kraft Precision Medicine Accelerator
The Multiple Myeloma Research Foundation (MMRF) has announced…
